Study Suggests S.Africa Variant Could Offer Better Immunity
Fahad Shabbir (@FahadShabbir) Published March 04, 2021 | 12:30 AM
Johannesburg, March 3 (UrduPoint / Pakistan Point News - 4th Mar, 2021 ) :A new preliminary study -- based on a small sample -- has suggested that people previously infected by the Covid-19 variant identified in South Africa may have better immunity against other coronavirus mutations, experts said Wednesday.
The findings, from a yet to be peer-reviewed research by the team of South African scientists who discovered the 501Y.V2 variant, raise hopes that vaccines modelled on the strain could protect against future mutations.
Only four percent of a sample of 55 patients who had 501Y.V2 failed to neutralise infection from the original coronavirus variant, according to data presented by a cohort of scientists under the Network Genomic Surveillance South Africa (NGS-SA).
Identified late last year, the variant became the dominant strain in the African nation worst hit by the pandemic, fuelling the second wave of infections and delaying the start of vaccinations in February.
Top virologist Tulio de Oliveira, told a video conference attended by senior government ministers that "the 501Y.V2 can produce a high level of antibodies that can neutralise itself," he said, adding that the immune response outperforms previous variants.
Health Minister Zweli Mkhize told the same meeting that the discovery was "good news for all" as it presented a huge boost to the control of the pandemic.
Coronavirus mutations -- some more contagious -- had put a damper on global vaccination programmes after existing shots were found to offer less protection against them.
Manufacturers have in recent weeks raced to tweak their formulas in response to the spread of newer variants.
US biotechnology company Moderna last week said it will begin in mid-March a clinical trial of a version of its vaccine specific to the South Africa variant.
Top government advisor and leading epidemiologist Salim Abdool Karim explained that shots developed by Pfizer/BioNTech and Moderna uses mRNA technology to elicit antibody production, and that the recent development bodes well for achieving immunity.
"These findings are basically telling us that we have a good prospect of success if we make a vaccine based on it," he said.
Related Topics
Recent Stories
UAF to ink MoU with Ethiopian universities
Scouts playing exemplary role in serving humanity: Dr Iqrar
Punjab Police cricket honored with shields, medals & CCI certificates
Bugti issues directives to operate circular road parking plaza
PML-N to become more strong under Nawaz Sharif: Rana Sanaullah
300 raids conducted on hideous of drug-dealers
IP rights crucial in achieving SDG : Jam Kamal
Commissioner urges effective action against electricity theft
PAK-EPA's clean lab boosts environmental analysis capabilities with advanced ICP ..
Romania court opens way for start of influencer Tate's trial
Japan International Cooperation Agency (JICA) delegation visits WSSCA
13 outlets sealed for violating Hepatitis preventive SOPs
More Stories From Miscellaneous
-
Modern Education Techniques: A pathway to achieve economic development
9 hours ago -
Kite Flying: From cultural festival to deadly sport
10 hours ago -
PDMA predicts gusty wind, rain with thunder, hails
3 days ago -
Iranian president Raisi given guard of honour at PM House
4 days ago -
Intellectuals, writers accolades Naseer Mirza on his literary contribution
5 days ago -
Bahawalpur Adabi Sangat hosts memorable mushaira
5 days ago
-
Cattle farming vital to alleviate poverty in rural areas
5 days ago -
Pakistan: A land of tourism, archeological wonders
5 days ago -
Transforming education sector: from job hunters to job creators
7 days ago -
Amjad Bobby remembered on 19th death anniversary for timeless contributions to music
11 days ago -
Legendary actor Nadeem’s 26 films released on Eid-ul-Fitr days in 50 years
12 days ago -
Besant Hall Cultural Centre to celebrate evening with Sanam Marvi on 26 April
12 days ago